Wayne H Winegarden
Commentary
Defining a Medicines’ Value versus its Price
When it comes to determining value, the U.S. health care system faces unique challenges. Without a better approach, the twin goals of continued innovation and broad-based drug affordability will be difficult, if not impossible, to maintain. Value assessment models are quickly becoming the approach du jour to overcome these challenges. However, value ...
Wayne H Winegarden
September 5, 2019
Health Care
Much-Publicized Report on Financial Returns on Cancer Treatments Contains Significant Flaws and Biases, Finds New PRI Brief
The World Health Organization (WHO) is advocating that the prices of cancer treatments are excessive, but its report that justifies this conclusion contains significant biases that drastically over-estimates the revenues multiple over research and development (R&D) costs, according to a new issue brief released today by the Center for Medical ...
Wayne H Winegarden
June 12, 2019
Business & Economics
New Study Finds ESG Funds Underperform Broader Investment Funds Over Long-Term
ESG funds that champion environmental and social causes have historically underperformed funds investing in the broader market over the long-term, so finds a new study released today by California-based, free-market think tank, the Pacific Research Institute. “In recent years, ESG funds have been presented to investors as socially responsible as ...
Wayne H Winegarden
May 22, 2019
Blog
NEW STUDY: Costly Regulations Hurt Entrepreneurship, Reform Needed to ‘Break Down Barriers’ for Jobs, Innovation
Costly regulations serve as a barrier to entrepreneurship, small business growth, innovation, and job opportunities to lift people into the middle class, concludes the first paper in a new series from the California-based, free-market think tank, the Pacific Research Institute. Click here to download the first paper in the Breaking ...
Wayne H Winegarden
April 3, 2019
Health Care
New PRI Study: Congress Has Some Unfinished Business – Acting to Repeal the Medical Device Tax
The controversial medical device tax hurts doctors, patients and manufacturers and should be repealed by Congress – according a new study released today by the California-based, free-market think tank, the Pacific Research Institute. Click here to download a copy of the study. “As the congressional session winds down, Congress has ...
Wayne H Winegarden
October 8, 2018
Business & Economics
New Study Finds High Prescription Drug Costs Are Not Driving Up U.S. Healthcare Costs
It’s easy for politicians and consumers to rage about the high price of prescription drugs, but Wayne Winegarden, Pacific Research Institute’s senior fellow in business and economics, said those prices are not to blame for the high cost of healthcare in the United States. Recently, U.S. Bernie Sanders has been ...
Wayne H Winegarden
May 16, 2017
Business & Economics
Going Broke One City at a Time: Municipal Bankruptcies in America
Municipalities have rarely defaulted on their debt. As a consequence, municipal debt is regarded as having an extremely low risk for investors. There are disconcerting trends developing that may change this historical view. The combination of the weak U.S. economy, high municipal debt levels, and large under-funded pension liabilities coupled ...
Wayne H Winegarden
January 10, 2014
Commentary
SPN 2009 Conference: Final Day
Publius Forum, November 4, 2009 The Wednesday session began with a breakfast address by James K. Glassman the former Under Secretary for Public Diplomacy and Public Affairs, U.S. Dept. of State during the George W. Bush administration. He spoke on Internet freedom (as opposed to net neutrality) and expressed his ...
Wayne H Winegarden
November 4, 2009
Defining a Medicines’ Value versus its Price
When it comes to determining value, the U.S. health care system faces unique challenges. Without a better approach, the twin goals of continued innovation and broad-based drug affordability will be difficult, if not impossible, to maintain. Value assessment models are quickly becoming the approach du jour to overcome these challenges. However, value ...
Much-Publicized Report on Financial Returns on Cancer Treatments Contains Significant Flaws and Biases, Finds New PRI Brief
The World Health Organization (WHO) is advocating that the prices of cancer treatments are excessive, but its report that justifies this conclusion contains significant biases that drastically over-estimates the revenues multiple over research and development (R&D) costs, according to a new issue brief released today by the Center for Medical ...
New Study Finds ESG Funds Underperform Broader Investment Funds Over Long-Term
ESG funds that champion environmental and social causes have historically underperformed funds investing in the broader market over the long-term, so finds a new study released today by California-based, free-market think tank, the Pacific Research Institute. “In recent years, ESG funds have been presented to investors as socially responsible as ...
NEW STUDY: Costly Regulations Hurt Entrepreneurship, Reform Needed to ‘Break Down Barriers’ for Jobs, Innovation
Costly regulations serve as a barrier to entrepreneurship, small business growth, innovation, and job opportunities to lift people into the middle class, concludes the first paper in a new series from the California-based, free-market think tank, the Pacific Research Institute. Click here to download the first paper in the Breaking ...
New PRI Study: Congress Has Some Unfinished Business – Acting to Repeal the Medical Device Tax
The controversial medical device tax hurts doctors, patients and manufacturers and should be repealed by Congress – according a new study released today by the California-based, free-market think tank, the Pacific Research Institute. Click here to download a copy of the study. “As the congressional session winds down, Congress has ...
New Study Finds High Prescription Drug Costs Are Not Driving Up U.S. Healthcare Costs
It’s easy for politicians and consumers to rage about the high price of prescription drugs, but Wayne Winegarden, Pacific Research Institute’s senior fellow in business and economics, said those prices are not to blame for the high cost of healthcare in the United States. Recently, U.S. Bernie Sanders has been ...
Going Broke One City at a Time: Municipal Bankruptcies in America
Municipalities have rarely defaulted on their debt. As a consequence, municipal debt is regarded as having an extremely low risk for investors. There are disconcerting trends developing that may change this historical view. The combination of the weak U.S. economy, high municipal debt levels, and large under-funded pension liabilities coupled ...
SPN 2009 Conference: Final Day
Publius Forum, November 4, 2009 The Wednesday session began with a breakfast address by James K. Glassman the former Under Secretary for Public Diplomacy and Public Affairs, U.S. Dept. of State during the George W. Bush administration. He spoke on Internet freedom (as opposed to net neutrality) and expressed his ...